Compounds > platinum
Page last updated: 2024-08-22

platinum and Cancer of Pancreas

platinum has been researched along with Cancer of Pancreas in 36 studies

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (13.89)29.6817
2010's16 (44.44)24.3611
2020's15 (41.67)2.80

Authors

AuthorsStudies
Bałaban, J; Chwalibog, A; Daniluk, K; Sawosz, E; Sosnowska, M; Strojny, B; Szczepaniak, J; Wierzbicki, M; Wójcik, B; Zielińska-Górska, M1
Anaya, DA; Carballido, E; Felder, S; Fleming, JB; Frakes, J; Imanirad, I; Kim, R; Knepper, T; Mo, Q; Permuth, JB; Sahin, IH; Somerer, K; Tan, E; Walko, C; Whiting, J; Xie, H1
Domchek, SM; Donze, A; Gosselin, MK; Karasic, T; Massa, R; Mick, R; O'Hara, M; Onyiah, C; Reiss, KA; Schneider, C; Teitelbaum, U; Tondon, R; Vonderheide, RH1
Albers, D; Kasper, S; Lahner, H; Markus, P; Mende, B; Mika, S; Reis, H; Rosery, V; Schmid, KW; Schuler, M; Schumacher, B; Siveke, JT; Stuschke, M; Treckmann, J; Wiesweg, M1
Horiguchi, K; Ishida, E; Matsumoto, S; Nakajima, Y; Nobusawa, S; Okada, S; Sekiguchi, S; Yamada, E; Yamada, M; Yamaguchi, N; Yokoo, H; Yoshino, S1
Arnold, D; Goekkurt, E; Kraeft, AL; Reinacher-Schick, A; Seufferlein, T; Venerito, M1
Berg, S; Davies, CL; Haram, M; Lage, J; Mjønes, P; Mühlenpfordt, M; Rønne, E; Snipstad, S1
Kanai, M; Kondo, T; Matsumori, T; Murakami, H; Muto, M; Nagai, K; Sunami, T; Uchida, Y; Uza, N; Yamada, A; Yamada, T; Yokode, M1
Amison, N; Atias, D; Bar, V; Beller, T; Ben-David, U; Berger, R; Denroche, RE; Dinstag, G; Eliezer, Y; Gallinger, SJ; Gavert, NS; Glick Gorman, Y; Golan, T; Haimov Talmoud, E; Halperin, S; Kinar, Y; Notta, F; O'Kane, GM; Peer, E; Raitses-Gurevich, M; Salpeter, SJ; Schvimer, M; Stossel, C; Straussman, R; Tal, R; Tirosh, I; Wilson, JM; Zhang, A; Zundelevich, A1
Chen, R; Fu, Z; He, R; Hu, C; Li, T; Lin, Q; Luo, Y; Sun, S; Tian, Q; Xia, R; Yuan, Y; Zheng, S; Zhou, Y1
Kojima, E; Kuba, H; Matsumura, M1
Lowery, MA1
Asagi, A; Furukawa, M; Furuse, J; Hara, H; Hosokawa, A; Ikeda, M; Kojima, M; Kojima, Y; Mizuno, N; Murohisa, G; Ohkawa, S; Okusaka, T; Okuyama, H; Shioji, K; Yamanaka, T1
Agafonova, J; Fedyanin, M; Menshikova, S; Pokataev, I; Polyanskaya, E; Popova, A; Rumyantsev, A; Tjulandin, S; Tryakin, A1
Alonso-Gordoa, T; Brabander, T; Cadiot, G; Caminoa, A; Capdevila, J; Chakrabarty, B; Couvelard, A; Cros, J; de Mestier, L; García Gómez-Muriel, MI; Garcia-Alvarez, A; Hernando, J; Kats-Ugurlu, G; Lamarca, A; Landolfi, S; Manoharan, P; Pavel, ME; Perrier, M; Ronot, M; Van Velthuysen, MF; Walenkamp, AM; Zandee, W1
Ramkissoon, S; Sorscher, S1
Furukawa, M; Furuse, J; Hara, K; Hashigo, S; Hijioka, S; Hosoda, W; Ikeda, M; Imamura, M; Ishii, H; Ito, T; Kanno, A; Kawaguchi, Y; Kitano, M; Kobayashi, N; Kodama, Y; Komoto, I; Maguchi, H; Matayoshi, N; Matsuo, K; Mine, T; Miyabe, K; Mizuno, N; Morizane, C; Murohisa, G; Nakamori, S; Notohara, K; Okusaka, T; Taguchi, H; Takagi, T; Tanaka, H; Tsuchiya, Y; Tsuji, A; Ueno, M; Yanagimoto, H; Yane, K; Yatabe, Y; Yoshida, T; Yoshitomi, H1
Bara, RO; Byers, LA; Cardnell, RJ; Gay, CM; Heymach, JV; Johnson, FM; Ma, J; Sen, T; Su, X; Tong, P; Wakefield, C; Wang, J1
Bronich, TK; Caffrey, T; Hollingsworth, MA; Lei, F; Lele, SM; Mehla, K; O'Connell, KA; Radhakrishnan, P; Sagar, S; Soni, KS; Thomas, D1
Banfi, D; Dyson, PJ; Kuttler, F; Turcatti, G; Varbanov, HP1
Chikuma, M; Komeda, S; Odani, A; Suzuki, T; Takayama, H; Yamori, T1
Guo, JC; Yang, SH1
De Souza, AL; Saif, MW2
Ahn, J; Cabral, H; Chida, T; Kataoka, K; Kim, A; Koga, Y; Liu, X; Matsumura, Y; Miura, Y; Nishiyama, N; Sato, R; Tsumura, R; Yamada, N; Yasunaga, M1
Anderson, MJ; Aust, D; Bailey, P; Barbour, A; Bassi, C; Biankin, AV; Bjerkvig, R; Bruxner, TJ; Chang, DK; Chantrill, LA; Chin, V; Chou, A; Christ, AN; Cloonan, N; Colvin, EK; Corbo, V; Cowley, MJ; Epari, K; Eshleman, JR; Fadlullah, MZ; Falconi, M; Fink, JL; Gill, AJ; Giry-Laterriere, M; Graham, JS; Grimmond, SM; Grützmann, R; Harliwong, I; Holmes, O; Hruban, RH; Humphrey, ES; Humphris, J; Iacobuzio-Donahue, CA; Idrisoglu, S; Jamieson, NB; Johns, AL; Jones, MD; Kassahn, KS; Kazakoff, SH; Kench, JG; Lawlor, RT; Lee, HC; Leonard, C; Maitra, A; Manning, S; Markham, E; Mawson, A; Merrett, ND; Miller, D; Morgan, RA; Musgrove, EA; Nagrial, AM; Newell, F; Nguyen, NQ; Niclou, SP; Nones, K; Nourbakhsh, E; Nourse, C; Pajic, M; Patch, AM; Pearson, JV; Pettitt, JA; Pilarsky, C; Pinese, M; Pinho, AV; Poudel, B; Quek, K; Quinn, MC; Robertson, AJ; Rooman, I; Samra, JS; Scarlett, CJ; Scarpa, A; Song, S; Steinmann, AM; Taylor, D; Tempero, MA; Toon, C; Tortora, G; Waddell, N; Wani, S; Wilson, PJ; Wolfgang, CL; Wood, S; Wu, J; Xu, Q; Zamboni, G; Zeps, N1
Cunningham, D; Ghaneh, P; Neoptolemos, JP; Smith, CT; Starling, N; Sultana, A1
Höhler, T; Oettle, H; Staib, L1
Li, J; Saif, MW1
Adenis, A; Conroy, T; Gavoille, C1
Komeda, S1
Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M1
Bengrine-Lefèvre, L; Bonnetain, F; Hammel, P; Hentic, O; Lévy, P; Louvet, C; Neuzillet, C; Raymond, E; Rebours, V; Rousseau, B; Ruszniewski, P1
Labianca, R; Merelli, B; Mosconi, S1
Brard, L; Kim, KK; Lange, TS; Shaw, SK; Singh, RK1
Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E1

Reviews

5 review(s) available for platinum and Cancer of Pancreas

ArticleYear
Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice.
    Oncology research and treatment, 2022, Volume: 45, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Pancreatic Neoplasms; Platinum

2022
Efficacy of platinum-based chemotherapy and prognosis of patients with pancreatic cancer with homologous recombination deficiency: comparative analysis of published clinical studies.
    ESMO open, 2020, Volume: 5, Issue:1

    Topics: Homologous Recombination; Humans; Mutation; Pancreatic Neoplasms; Platinum; Prognosis

2020
[Treatment of advanced pancreatic carcinoma].
    Onkologie, 2008, Volume: 31 Suppl 5

    Topics: Antineoplastic Agents; Deoxycytidine; Erlotinib Hydrochloride; Gemcitabine; Humans; Palliative Care; Pancreatic Neoplasms; Platinum; Quinazolines; Terminal Care

2008
Metastatic pancreatic cancer: old drugs, new paradigms.
    Current opinion in oncology, 2011, Volume: 23, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Pancreatic Ductal; Clinical Trials, Phase III as Topic; Deoxycytidine; Erlotinib Hydrochloride; Fluorouracil; Gemcitabine; Heparin; Humans; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Platinum; Quinazolines

2011
[Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Design; Drug Discovery; Drug Resistance, Neoplasm; Humans; Mice; Molecular Conformation; Organoplatinum Compounds; Pancreatic Neoplasms; Platinum; Pyrazoles; Tumor Cells, Cultured

2012

Trials

2 trial(s) available for platinum and Cancer of Pancreas

ArticleYear
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
    The Lancet. Oncology, 2022, Volume: 23, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Hypertension; Immune Checkpoint Inhibitors; Indazoles; Ipilimumab; Nivolumab; Pancreatic Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2022
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial).
    Neuroendocrinology, 2020, Volume: 110, Issue:11-12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Neuroendocrine; Drug-Related Side Effects and Adverse Reactions; Everolimus; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatic Neoplasms; Platinum; Progression-Free Survival; Prospective Studies

2020

Other Studies

29 other study(ies) available for platinum and Cancer of Pancreas

ArticleYear
Effects of Metallic and Carbon-Based Nanomaterials on Human Pancreatic Cancer Cell Lines AsPC-1 and BxPC-3.
    International journal of molecular sciences, 2021, Nov-09, Volume: 22, Issue:22

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Diamond; Fullerenes; Gene Expression Regulation, Neoplastic; Gold; Graphite; Humans; Nanostructures; Neoplasm Proteins; Pancreatic Neoplasms; Platinum; Silver

2021
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers.
    American journal of clinical oncology, 2022, 04-01, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Gastrointestinal Neoplasms; Homologous Recombination; Humans; Male; Mutation; Pancreatic Neoplasms; Platinum; Prognosis

2022
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:8

    Topics: Etoposide; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum; Prognosis; Retrospective Studies; Stomach Neoplasms

2023
A case of insulinoma-induced hypoglycemia managed by Dexcom G4 Platinum.
    Neuro endocrinology letters, 2022, Sep-16, Volume: 43, Issue:3

    Topics: Adult; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Insulinoma; Pancreatic Neoplasms; Platinum

2022
Ultrasound and Microbubbles Increase the Uptake of Platinum in Murine Orthotopic Pancreatic Tumors.
    Ultrasound in medicine & biology, 2023, Volume: 49, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Mice; Microbubbles; Oxaliplatin; Pancreatic Neoplasms; Platinum; Tumor Microenvironment; Ultrasonography

2023
Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.
    Pancreas, 2022, 10-01, Volume: 51, Issue:9

    Topics: Adult; Bile Duct Neoplasms; BRCA1 Protein; BRCA2 Protein; Carcinoma, Acinar Cell; Genetic Predisposition to Disease; Germ Cells; Germ-Line Mutation; Humans; Male; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Platinum

2022
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting.
    Cancer discovery, 2023, 08-04, Volume: 13, Issue:8

    Topics: Carcinoma, Pancreatic Ductal; Humans; Mutation; Pancreatic Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2023
Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer.
    Journal of experimental & clinical cancer research : CR, 2023, Nov-28, Volume: 42, Issue:1

    Topics: Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Extracellular Vesicles; Humans; Oxaliplatin; Pancreatic Neoplasms; Platinum; RNA; Sumoylation

2023
[Responsiveness of well-differentiated PanNET G3 to platinum-based chemotherapy: a case report].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2019, Volume: 116, Issue:11

    Topics: Antineoplastic Agents; Humans; Neoplasm Grading; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum

2019
Genotype-phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer.
    British journal of cancer, 2020, Volume: 122, Issue:3

    Topics: BRCA1 Protein; BRCA2 Protein; Fanconi Anemia Complementation Group N Protein; Genetic Association Studies; Germ Cells; Humans; Pancreatic Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2020
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs.
    Endocrine-related cancer, 2021, 06-23, Volume: 28, Issue:8

    Topics: Adenocarcinoma; Etoposide; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum; Retrospective Studies; Somatostatin; Treatment Outcome

2021
Rapid Progression of Metastatic Pancreatic Adenocarcinoma During Platinum-Based Therapy in a Patient Harboring a Pathogenic BRCA2 Germline Variant.
    The oncologist, 2021, Volume: 26, Issue:11

    Topics: Adenocarcinoma; BRCA2 Protein; Disease Progression; Germ-Line Mutation; Humans; Neoplasm Metastasis; Pancreatic Neoplasms; Platinum; United States

2021
Rb Loss and
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Aug-15, Volume: 23, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asian People; Biomarkers, Tumor; Female; Humans; Japan; Male; Middle Aged; Mutation; Neoplasm Grading; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Platinum; Prognosis; Proto-Oncogene Proteins p21(ras); Retinoblastoma Protein; Survival Analysis

2017
Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 01-01, Volume: 25, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Aurora Kinase A; Cisplatin; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Pancreatic Neoplasms; Platinum; Proto-Oncogene Proteins c-bcl-2; Small Cell Lung Carcinoma; Software

2019
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer.
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 370, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Synergism; Gels; Gemcitabine; Humans; Mice; Mice, Nude; Nanostructures; Pancreatic Neoplasms; Platinum; Polymers

2019
Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis.
    PloS one, 2019, Volume: 14, Issue:1

    Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Repositioning; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; High-Throughput Screening Assays; Humans; Lung Neoplasms; Microscopy, Fluorescence; Pancreatic Neoplasms; Platinum; Prognosis

2019
Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Metallomics : integrated biometal science, 2013, Volume: 5, Issue:5

    Topics: Animals; Antineoplastic Agents; Body Weight; Cell Death; Cell Line, Tumor; Humans; Mice; Mice, Nude; Molecular Conformation; Organoplatinum Compounds; Pancreatic Neoplasms; Platinum; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays

2013
Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study.
    International journal of clinical oncology, 2014, Volume: 19, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Platinum; Retrospective Studies

2014
Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions.
    JOP : Journal of the pancreas, 2014, Mar-10, Volume: 15, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Humans; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Platinum; Treatment Outcome

2014
Squamous cell carcinoma of the pancreas.
    JOP : Journal of the pancreas, 2014, Nov-28, Volume: 15, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Humans; Pancreatic Neoplasms; Platinum

2014
Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer.
    Biomaterials, 2015, Volume: 39

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Mice; Micelles; Microscopy, Confocal; Nanoparticles; Pancreatic Neoplasms; Platinum; Polymers

2015
Whole genomes redefine the mutational landscape of pancreatic cancer.
    Nature, 2015, Feb-26, Volume: 518, Issue:7540

    Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; DNA Mutational Analysis; DNA Repair; Female; Genes, BRCA1; Genes, BRCA2; Genetic Markers; Genome, Human; Genomic Instability; Genomics; Genotype; Humans; Mice; Mutation; Pancreatic Neoplasms; Platinum; Point Mutation; Poly(ADP-ribose) Polymerase Inhibitors; Xenograft Model Antitumor Assays

2015
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison.
    BMC cancer, 2008, Jul-08, Volume: 8

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials, Phase III as Topic; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Gemcitabine; Humans; Irinotecan; Meta-Analysis as Topic; Pancreatic Neoplasms; Platinum; Proportional Hazards Models; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome

2008
Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    JOP : Journal of the pancreas, 2009, Jul-06, Volume: 10, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Erlotinib Hydrochloride; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Platinum; Quinazolines; Treatment Outcome

2009
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
    Endocrine-related cancer, 2012, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome

2012
FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts.
    World journal of gastroenterology, 2012, Sep-07, Volume: 18, Issue:33

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fluorouracil; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Platinum; Retrospective Studies; Survival Rate; Treatment Failure; Treatment Outcome

2012
Treatment of advanced pancreatic cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23 Suppl 10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Platinum

2012
A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.
    Gynecologic oncology, 2008, Volume: 109, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Female; Humans; Indoles; Isocyanates; Male; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Pancreatic Neoplasms; Platinum; Prostatic Neoplasms

2008
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
    Anti-cancer drugs, 2001, Volume: 12, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Hypertension; Hypocalcemia; Hypotension; Infusions, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Paclitaxel; Pancreatic Neoplasms; Platinum; Prednisone; Premedication; Retrospective Studies; Vincristine

2001